A researcher at the University of Missouri School of Medicine has received a $1.8 million grant from the National Institutes of Health to study asthma triggers. The asthma study will focus on ...
Among pediatric patients with hereditary angioedema, on-demand sebetralstat was generally safe and used within a median time of 30 minutes after attack onset, according to interim phase 3 trial ...
A new proposal in the New York State Assembly would require health insurance plans to fully cover asthma inhalers with no out ...
Clinicians met in Orlando for the 2025 ACAAI Annual Scientific Meeting to present the latest research on allergy, asthma, and ...
We congratulate Celeste Porsbjerg and colleagues for their Series paper1 addressing a key question in asthma care: the definition of the ideal candidate for biological therapy. Porsbjerg and ...
For anyone with asthma, keeping symptoms under control can sometimes feel like a constant struggle. Between seasonal weather ...
"Together, these highlight the fact that oral corticosteroids contribute to burden, even intermittently used," Oppenheimer ...
InvestorsHub on MSN
Nektar Therapeutics Shares Rise After Positive Asthma Data in Atopic Dermatitis Patients
Nektar Therapeutics (NASDAQ:NKTR) shares climbed 3.6% on Monday after the biotech firm unveiled encouraging new data showing ...
(THE CONVERSATION) Asthma is a common, serious and difficult-to-manage chronic health condition. In the U.S., 1 in 7 people are diagnosed with asthma, and that number is rising. Over the years, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback